FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathleen Wyvill

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Anatomy

CD4-Positive T-Lymphocytes

Concepts & Ideas

Co-author Network

Publications

TOP 3
Alex Ray; Thomas Uldrick; Kathleen M Wyvill; Robert Yarchoan; Karen Aleman; Nazzarena Labo; Robert Leighty; Richard F Little; Vickie Marshall; Mark N Polizzotto; Denise Whitby
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
Thomas Uldrick; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Wendy Bernstein; PALLAVI KUMAR; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Robert Yarchoan
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Thomas Uldrick; Victoria Wang; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Giovanna Tosato; Robert Yarchoan
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathleen Wyvill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alex Ray; Thomas Uldrick; Kathleen M Wyvill; Robert Yarchoan; Karen Aleman; Nazzarena Labo; Robert Leighty; Richard F Little; Vickie Marshall; Mark N Polizzotto; Denise Whitby
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
The Journal of infectious diseases 2012;205(11):1665-76.
2012: Thomas Uldrick; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Wendy Bernstein; PALLAVI KUMAR; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Robert Yarchoan
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(13):1476-83.
2011: Thomas Uldrick; Victoria Wang; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Giovanna Tosato; Robert Yarchoan
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Blood 2011;117(26):6977-86.
2011: Krista A Delviks-Frankenberry; Rachel K Bagni; Chawaree Chaipan; Kathleen M Wyvill; Robert Yarchoan; Vinay Pathak
Lack of Detection of Xenotropic Murine Leukemia Virus-Related Virus in HIV-1 Lymphoma Patients.
Advances in virology 2011;2011():797820.
2010: Thomas Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(3):350-8.
2010: Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Kathleen M Wyvill; Richard F Little; Michael Iadarola; Joseph A Kovacs; Robert Yarchoan
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.
The Journal of infectious diseases 2010;201(12):1919-22.
2007: Richard F Little; Karen Aleman; PALLAVI KUMAR; Kathleen M Wyvill; James M Pluda; Elizabeth Read-Connole; Victoria Wang; Stefania Pittaluga; Andrew T Catanzaro; Seth M Steinberg; Robert Yarchoan
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.
Blood 2007;110(13):4165-71.
2007: Robert Yarchoan; James M Pluda; Kathleen M Wyvill; Karen Aleman; Isaac R Rodriguez-Chavez; Giovanna Tosato; Andrew T Catanzaro; Seth M Steinberg; Richard F Little
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
Critical reviews in immunology 2007;27(5):401-14.
2006: Richard F Little; James M Pluda; Kathleen M Wyvill; Isaac R Rodriguez-Chavez; Giovanna Tosato; Andrew T Catanzaro; Seth M Steinberg; Robert Yarchoan
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.
Blood 2006;107(12):4650-7.
2006: Abby Vogel; Bahar Dasgeb; Moinuddin Hassan; Franck Amyot; Victor Chernomordik; Yang Tao; Stavros G Demos; Kathleen M Wyvill; Karen Aleman; Richard Little; Robert Yarchoan; Amir H Gandjbakhche
Using quantitative imaging techniques to assess vascularity in AIDS-related Kaposi's sarcoma.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2006;1():232-5.
2004: Moinuddin Hassan; Richard F Little; Abby Vogel; Karen Aleman; Kathleen M Wyvill; Robert Yarchoan; Amir H Gandjbakhche
Quantitative assessment of tumor vasculature and response to therapy in kaposi's sarcoma using functional noninvasive imaging.
Technology in cancer research & treatment 2004;3(5):451-7.
2003: Sabrina Villalba; Ombretta Salvucci; Yoshiyasu Aoki; Maria De La Luz Sierra; Ghanshyam Gupta; David Davis; Kathleen M Wyvill; Richard Little; Robert Yarchoan; Giovanna Tosato
Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo.
Journal of leukocyte biology 2003;74(5):880-8.
2002: Antonio Valentin; margherita rosati; Daniel J Patenaude; Angelos Hatzakis; Leondios G Kostrikis; Marios Lazanas; Kathleen M Wyvill; Robert Yarchoan; George Pavlakis
Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):7015-20.
2001: Yoshiyasu Aoki; Robert Yarchoan; Kathleen M Wyvill; S Okamoto ; Richard F Little; Giovanna Tosato
Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.
Blood 2001;97(7):2173-6.
2000: Charles B Foster; Thomas Lehrnbecher; S Samuels; S Stein; F Mol; Julia A Metcalf; Kathleen M Wyvill; Seth M Steinberg; J Kovacs; Andrew Blauvelt; Robert Yarchoan; STEPHEN CHANOCK
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.
Blood 2000;96(7):2562-7.
2000: Richard F Little; Kathleen M Wyvill; James M Pluda; Lauri Welles; Vickie Marshall; William D Figg; Fonda M Newcomb; Giovanna Tosato; Ellen G Feigal; Seth M Steinberg; Denise Whitby; James J Goedert; Robert Yarchoan
Activity of thalidomide in AIDS-related Kaposi's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2593-602.
2000: Thomas Lehrnbecher; Charles B Foster; S Zhu; David Venzon; Seth M Steinberg; Kathleen M Wyvill; Julia A Metcalf; SS Cohen; J Kovacs; Robert Yarchoan; Andrew Blauvelt; STEPHEN CHANOCK
Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men.
Blood 2000;95(7):2386-90.
1999: Rachel Humphrey; Kathleen M Wyvill; BY Nguyen; LE Shay; David R Kohler; Seth M Steinberg; T Ueno; T Fukasawa; M Shintani; Hideya Hayashi; Hiroaki Mitsuya; Robert Yarchoan
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection.
Antiviral research 1999;41(1):21-33.
1998: SB Williams; M Sano; N Smith; McDonald Horne; Robert Yarchoan; Kathleen M Wyvill; Steven L Zeichner; P Taylor; T Knudson; HR Gralnick
Glycocalicin levels in the plasma of HIV+ patients: an indicator of platelet turnover.
The Journal of laboratory and clinical medicine 1998;132(4):303-7.
1998: Mark F Kavlick; Kathleen M Wyvill; Robert Yarchoan; Hiroaki Mitsuya
Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy.
The Journal of infectious diseases 1998;177(6):1506-13.
1998: Lauri Welles; MW Saville; JA Lietzau; James M Pluda; Kathleen M Wyvill; I Feuerstein; William D Figg; Richard M Lush; J Odom; Wyndham H Wilson; M T Fajardo; Rachel Humphrey; Ellen G Feigal; David Tuck; Seth M Steinberg; S Broder; Robert Yarchoan
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1112-21.
1997: William D Figg; James M Pluda; Richard M Lush; MW Saville; Kathleen M Wyvill; Eddie Reed; Robert Yarchoan
The pharmacokinetics of TNP-470, a new angiogenesis inhibitor.
Pharmacotherapy 1997;17(1):91-7.
1996: Rachel Humphrey; T R O'Brien; Fonda M Newcomb; H Nishihara; Kathleen M Wyvill; G A Ramos; MW Saville; James J Goedert; Stephen E Straus; Robert Yarchoan
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
Blood 1996;88(1):297-301.
1995: B Y Nguyen; Robert Yarchoan; Kathleen M Wyvill; D J Venzon; James M Pluda; Hiroaki Mitsuya; S Broder
Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infection.
The Journal of infectious diseases 1995;171(5):1180-9.
1994: Robert Yarchoan; J A Lietzau; B Y Nguyen; Otis W Brawley; James M Pluda; MW Saville; Kathleen M Wyvill; Seth M Steinberg; Riad Agbaria; Hiroaki Mitsuya
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
The Journal of infectious diseases 1994;169(1):9-17.
1993: B Y Nguyen; L E Shay; Kathleen M Wyvill; James M Pluda; Otis W Brawley; R B Cohen; Scott M Whitcup; D J Venzon; S Broder; Robert Yarchoan
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
The Journal of infectious diseases 1993;168(4):810-7.
1993: James M Pluda; D J Venzon; G Tosato; J Lietzau; Kathleen M Wyvill; D L Nelson; Elaine S Jaffe; Judith E Karp; S Broder; Robert Yarchoan
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1099-107.
1992: L E Shay; Kathleen M Wyvill
Didanosine use in the adult HIV patient.
The Nurse practitioner 1992;17(12):59-64.
1992: S Aoki-Sei; Robert Yarchoan; S Kageyama; D T Hoekzema; James M Pluda; Kathleen M Wyvill; S Broder; Hiroaki Mitsuya
Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
AIDS research and human retroviruses 1992;8(7):1263-70.
1991: N R Hartman; Robert Yarchoan; James M Pluda; R V Thomas; Kathleen M Wyvill; K P Flora; S Broder; David G Johns
Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications.
Clinical pharmacology and therapeutics 1991;50(3):278-85.
1991: Robert Yarchoan; D J Venzon; James M Pluda; J Lietzau; Kathleen M Wyvill; A A Tsiatis; Seth M Steinberg; S Broder
CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.
Annals of internal medicine 1991;115(3):184-9.
1990: L E Shay; R V Thomas; Kathleen M Wyvill; D O Adamo; J F Jenkins
New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).
Cancer nursing 1990;13(5):269-77.
1990: Robert Yarchoan; James M Pluda; R V Thomas; Hiroaki Mitsuya; Pim Brouwers; Kathleen M Wyvill; N Hartman; David G Johns; S Broder
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex.
Lancet 1990;336(8714):526-9.
1990: James M Pluda; Robert Yarchoan; Elaine S Jaffe; IM Feuerstein; D Solomon; Seth M Steinberg; Kathleen M Wyvill; A Raubitschek; D Katz; S Broder
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
Annals of internal medicine 1990;113(4):276-82.
1990: Robert Yarchoan; James M Pluda; Carlo Federico Perno; Hiroaki Mitsuya; R V Thomas; Kathleen M Wyvill; S Broder
Initial clinical experience with dideoxynucleosides as single agents and in combination therapy.
Annals of the New York Academy of Sciences 1990;616():328-43.